HealthNewsAPI
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses - NBC News
Overview
An experimental drug, daraxonrasib, produced striking early results in advanced pancreatic cancer, roughly doubling patients’ survival in a recent trial. The newly released trial data reinforce the drug’s potential and suggest it may also be active against other tumors driven by similar KRAS mutations, including some lung, colon and ovarian cancers. While the result bolsters momentum for KRAS-targeted drug development and interest in complementary approaches like personalized vaccines, larger trials and broader validation are still required before it changes standard care.
Entities
ORGNBC NewsPERSONDr. Zev Wainberg
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 5 · Connections: 4
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.